Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for treating tumors of high unmet need in ocular and urologic oncology. It is developing AU-011, a VDC candidate for the treatment of primary choroidal melanoma that is in phase III clinical trial. The company also develops AU-011 for additional ocular oncology indications, including choroidal metastases and is in Phase 2 dose-escalation trial. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
What is the ticker symbol for Aura Biosciences, Inc.? What does AURA stand for in stocks?
AURA is the stock ticker symbol of Aura Biosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of Aura Biosciences, Inc. (AURA)?
As of Fri Dec 06 2024, market cap of Aura Biosciences, Inc. is 448.06 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of AURA stock?
You can check AURA's fair value in chart for subscribers.
Is Aura Biosciences, Inc. a good stock to buy?
The fair value guage provides a quick view whether AURA is over valued or under valued. Whether Aura Biosciences, Inc. is cheap or expensive depends on the assumptions which impact Aura Biosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AURA.